228 related articles for article (PubMed ID: 29698802)
1. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
Stella M; Chinello C; Cazzaniga A; Smith A; Galli M; Piga I; Grasso A; Grasso M; Del Puppo M; Varallo M; Bovo G; Magni F
J Proteomics; 2019 Jan; 191():38-47. PubMed ID: 29698802
[TBL] [Abstract][Full Text] [Related]
2. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
4. Tumor size, stage and grade alterations of urinary peptidome in RCC.
Chinello C; Cazzaniga M; De Sio G; Smith AJ; Grasso A; Rocco B; Signorini S; Grasso M; Bosari S; Zoppis I; Mauri G; Magni F
J Transl Med; 2015 Oct; 13():332. PubMed ID: 26482227
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and prognostic significance of manganese superoxide dismutase in clear cell renal cell carcinoma.
Zhao Z; Lu J; Qu H; Wang Z; Liu Q; Yang X; Liu S; Ge J; Xu Y; Li N; Yuan Y
Hum Pathol; 2018 Oct; 80():87-93. PubMed ID: 29935195
[TBL] [Abstract][Full Text] [Related]
6. Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.
Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Srigley JR; Coughlin G; Dunglinson N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Yaxley J; Samaratunga H
Histopathology; 2017 Dec; 71(6):918-925. PubMed ID: 28718911
[TBL] [Abstract][Full Text] [Related]
7. Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.
Gianazza E; Chinello C; Mainini V; Cazzaniga M; Squeo V; Albo G; Signorini S; Di Pierro SS; Ferrero S; Nicolardi S; van der Burgt YE; Deelder AM; Magni F
J Proteomics; 2012 Dec; 76 Spec No.():125-40. PubMed ID: 22868251
[TBL] [Abstract][Full Text] [Related]
8. Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin-fixed paraffin-embedded adenocarcinoma tissue sections.
Djidja MC; Francese S; Loadman PM; Sutton CW; Scriven P; Claude E; Snel MF; Franck J; Salzet M; Clench MR
Proteomics; 2009 May; 9(10):2750-63. PubMed ID: 19405023
[TBL] [Abstract][Full Text] [Related]
9. Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma.
Chinello C; Stella M; Piga I; Smith AJ; Bovo G; Varallo M; Ivanova M; Denti V; Grasso M; Grasso A; Del Puppo M; Zaravinos A; Magni F
J Proteomics; 2019 Jan; 191():29-37. PubMed ID: 29689304
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
Yang J; Yang J; Gao Y; Zhao L; Liu L; Qin Y; Wang X; Song T; Huang C
PLoS One; 2014; 9(11):e111364. PubMed ID: 25368985
[TBL] [Abstract][Full Text] [Related]
11. KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2.
Cocco E; Leo M; Canzonetta C; Di Vito S; Mai A; Rotili D; Di Napoli A; Vecchione A; De Nunzio C; Filetici P; Stoppacciaro A
Clin Epigenetics; 2018; 10():44. PubMed ID: 29632619
[TBL] [Abstract][Full Text] [Related]
12. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
Yang J; Liu P; Tian M; Li Y; Chen W; Li X
Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
[TBL] [Abstract][Full Text] [Related]
13. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
[TBL] [Abstract][Full Text] [Related]
14. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis.
Delahunt B; McKenney JK; Lohse CM; Leibovich BC; Thompson RH; Boorjian SA; Cheville JC
Am J Surg Pathol; 2013 Mar; 37(3):311-22. PubMed ID: 23348209
[TBL] [Abstract][Full Text] [Related]
15. Prediction of ISUP grading of clear cell renal cell carcinoma using support vector machine model based on CT images.
Sun X; Liu L; Xu K; Li W; Huo Z; Liu H; Shen T; Pan F; Jiang Y; Zhang M
Medicine (Baltimore); 2019 Apr; 98(14):e15022. PubMed ID: 30946334
[TBL] [Abstract][Full Text] [Related]
16. Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues.
Vieira de Ribeiro AJ; Sandim V; Ornellas AA; Reis RS; Domont G; Alves G
Int Braz J Urol; 2013; 39(1):83-94. PubMed ID: 23510786
[TBL] [Abstract][Full Text] [Related]
17. Orai1 Expression Is Closely Related with Favorable Prognostic Factors in Clear Cell Renal Cell Carcinoma.
Lkhagvadorj S; Kim JH; Oh SS; Lee MR; Jung JH; Chung HC; Cha SK; Eom M
J Korean Med Sci; 2016 Jun; 31(6):879-85. PubMed ID: 27247496
[TBL] [Abstract][Full Text] [Related]
18. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary analysis of differentially expressed proteins of clear-cell renal cell carcinoma by comparative proteomic technologies].
Yang J; Li X; Tian MJ; Wang LN; Cheng TT; Chen W
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):571-6. PubMed ID: 23158988
[TBL] [Abstract][Full Text] [Related]
20. Mutational heterogeneity between different regional tumour grades of clear cell renal cell carcinoma.
Ferronika P; Kats-Ugurlu G; Haryana SM; Utoro T; Rinonce HT; Danarto R; de Lange K; Terpstra MM; Sijmons RH; Westers H; Kok K
Exp Mol Pathol; 2020 Aug; 115():104431. PubMed ID: 32259515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]